stockrowCytokinetics, Incorporated (CYTK) vs ImmunityBio, Inc. (IBRX)
- Cytokinetics, Incorporated CYTK 54.30 −2.25%
- ImmunityBio, Inc. IBRX 8.67 +8.24%
Cytokinetics, Incorporated and ImmunityBio, Inc. are both Biotechnology companies. Cytokinetics, Incorporated and ImmunityBio, Inc. are of similar size ($8.5B and $7.7B). ImmunityBio, Inc. grew revenue faster over the last twelve months: 192.9% against 29.9%. ImmunityBio, Inc. has the higher net margin (−598.6% vs −686.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, ImmunityBio, Inc. leads on 13 and Cytokinetics, Incorporated on 3.
Valuation
Profitability
| Metric | CYTK | IBRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 99.34% | 65.16% |
| Operating margin | (625.15%) | (151.88%) | 0.00% |
| Net margin | (686.63%) | (598.56%) | 0.00% |
| Free cash flow margin | (519.53%) | (173.76%) | 0.00% |
| Return on equity | 184.71% | 122.85% | (50.12%) |
| Return on assets | (47.70%) | (192.58%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack